GENAGRID - Bioinformatic services for genetic association studies using high-performance grid computation
From 01-12-2008 to 30-11-2012
Description
The goals of this project are (1) a platform for the automated, text-mining based construction of biomedical knowledge bases, (2) efficient inference methods for probabilistic knowledge bases and Bayesian models, (3) decision support tools for genomic study design, (4) general purpose and dedicated statistical methods for the analysis of relevance of variables, (5) interpretational tools for genomic data analysis, (6) services for the parallelization/”griding” of the „text-mining”, inference, inductive methods, (7) pharmacogenomic discovery tools to support rational drug design by probabilistic fusion of information from chemoinformatics and GA research, (8) biomedical tools to support (8a) clinical genetic consultancy based on commercially avaialable personal genotypic information, (8b) to support of the design of disease-specific and general genotyping kits with focus on the Hungarian/EEU/EU population, and (8c) to support the principled information dissemination related to commercially avaialable genotypic information to balance public awareness and to increase their potential preventive effects. We integrate them in (9) GENAGRID, a high-performance grid hosting databases, knowledge-bases, services, and methods for genomic R&D activities and applications.Team
- Peter Antal, Promoter (External)
- Bart De Moor, Team member
- Yves Moreau, Team member
Financing
Funding: OTHER - Other Funding Agencies
Program/Grant Type: Other - Other
Events
2/09/2024:
PhD defense - Martijn Oldenhof
Machine Learning for Advanced Chemical Analysis and Structure Recognition in Drug Discovery
3/09/2024:
Meet the Jury Igor Tetko on Advanced Machine Learning in Drug Discovery
12/09/2024:
Multimodal analysis of cell-free DNA for sensitive cancer detection in low-coverage and low-sample settings
Seminar by Antoine Passemiers
News
STADIUS Alumni Herman Verrelst – new CEO of Biocartis
08 June 2017
Herman Verrelst, the founder of KU Leuven spin-off Cartagenia, who has been working in Silicon Valley, US for the last few years will be returning to Belgium to follow the steps of Rudi Pauwels as CEO of the Belgian diagnostic company, Biocartis.
Supporting healthcare policymaking via machine learning – batteries included!
29 May 2017
STADIUS takes the lead in the data analytics efforts in an ambitious European Project MIDAS.
Marc Claesen gives an interview about his PhD for the magazine of the Faculty of Engineering Sciences "Geniaal"
10 February 2017
Did you know that in Belgium approximately one third of type 2 diabetes patients are unaware of their condition?
Joos Vandewalle is nieuwe voorzitter KVAB
09 October 2016
Op 5 oktober 2016 heeft de Algemene Vergadering van de Academie KVAB Joos Vandewalle verkozen tot voorzitter van de KVAB.